Abstract
For many years, much attention has been focused on immunological studies in leukemia. This level of attention and effort has been disproportionately high, relative to the clinical frequency of leukemia compared to other types of neoplastic diseases. This may be accounted for by several important factors: (a) A considerable proportion of tumors arising spontaneously or induced in experimental animals, especially rodents, are leukemias or lymphomas. (b) The neoplastic leukemic cells are directly accessible in the peripheral blood or bone marrow, and there has been little or no need to use disaggregation or other procedures to obtain high yields of neoplastic cells. In many instances, it is possible to obtain very large numbers of leukemic cells virtually uncontaminated by normal cells. (c) Compared to carcinomas or sarcomas, it has been relatively easy to obtain the normal cellular counterparts of the various types of leukemic cells. This has provided an unusual opportunity to compare the normal processes of cell differentiation and the normal cell surface markers to the neoplastic processes and leukemia-associated markers.
Keywords
- Chronic Lymphocytic Leukemia
- Acute Leukemia
- Blast Cell
- Murine Leukemia Virus
- Chronic Lymphocytic Leukemia Patient
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson, S. A., and Stephenson, J. R., 1973, Independent segregation of loci for activation of biologically distinguishable RNA C-type virus in murine cells, Proc. Nat. Acad. Sci. U.S.A. 70:2055–2058.
Aisenberg, A., Bloch, K., and Long, J., 1973, Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders, Am. J. Med. 55:184–191.
Anderson, P. W., Klein, D. L., Bias, W. B., Mullins, G. M., Burke, P. J., and Santos, G. W., 1974, Cell-mediated immunological reactivity of patients and siblings to blast cells from adult acute leukemias, IsraelJ. Med. Sci. 10:1033–1051.
Aoki, T., and Johnson, P. A., 1973, Suppression of G (Gross) leukemia cell surface antigens: A kind of antigenic modulation, J. Nat. Cancer Inst. 49:183–189.
Aoki, T., Boyse, E. A., and Old, L. J., 1966, Occurrence of natural antibody to the G (Gross) leukemia antigen in mice. Cancer Res. 25:1415–1419.
Aoki, T., Boyse, E. A., and Old, L. J., 1968, Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice, J. Nat. Cancer Inst. 41:89–96.
Aoki, T., Boyse, E. A., Old, L. J., de Harven, E., Hammerling, U., and Wood, H. A., 1970a, G (Gross) and H-2 cell surface antigens: Location on Gross leukemia cells by electron microscopy with visually labeled antibody, Proc. Nat. Acad. Sci. U.S.A. 65:569–576.
Aoki, T., Stück, B., Old, L. J., Hammerling, U., and de Harven, E., 1970b, E antigen: A cell-surface antigen of C57BL leukemia, Cancer Res. 30:244–251.
Aoki, T., Herberman, R. B., Johnson, P. A., Iiu, M., and Sturm, M. M., 1972, Wild-type Gross leukemia virus: Classification of soluble antigens (GSA), J. Virol. 10:1208–1219.
Aoki, T., Huebner, R., Chang, K., Sturm, M., and Liu, M., 1974, Diversity of envelope antigens on murine type-C RNA viruses, J. Nat. Cancer Inst. 52:1189–1197.
Aoki, T., Herberman, R. B., and Liu, M., 1975, Heterogeneity of surface antigens on endogenous type C virus-producing cell sublines derived from a clonal line of BALB/3T3 cells, Intervirology 5:31–42.
Baker, M. A., Taub, R. N., Brown, S. M., and Ramachandar, K., 1974, Delayed cutaneous hypersensitivity in leukemic patients to autologous blast cells, Br. J. Hematol. 27:627–633.
Baldwin, R. W., Embleton, M. J., Price, M. R., and Robins, A., 1974, Immunity in the tumor-bearing host and its modification by serum factors, Cancer 34:1452–1460.
Barker, A., and Waksal, S., 1974, Thymus-derived lymphocyte differentiation and lymphocytic leukemias, Cell. Immunol. 12:140–149.
Bates, H. A., Bankole, R. O., and Swaim, W. R., 1969, Immunofluorescence studies in human leukemia, Blood 34:430–440.
Bauer, H., 1974, Virion and tumor cell antigens of C-type RNA tumor viruses, Adv. Cancer Res. 20:275–315.
Bauer, H., Bubenik, J., Graf, T., and Allgaier, C., 1969, Induction of transplantation resistance to Rous sarcoma isograft by avian leukosis virus, Virology 39:482–490.
Belpomme, D., Dantchev, D., Durusquec, E., Grandjon, D., Huchet, R., Pouillart, P., Schwarzenberg, L., Amiel, J. L., and Mathé, G., 1974, T and B lymphocyte markers on the neoplastic cell of 20 patients with acute and 10 patients with chronic lymphoid leukemia, Biomedicine 20:109–118.
Bentwich, Z., Weiss, D., Sulitzeanu, D., 1972, Antigenic changes on the surface of lymphocytes from patients with chronic lymphocytic leukemia, Cancer Res. 32:1375–1383.
Berenson, J. R., Einstein, A. B., Jr., and Fefer, A., 1975, Syngeneic adoptive immunotherapy and chemotherapy of Friend leukemia: Requirement for T cells, J. Immunol 115:234–238.
Bianco, C., Patrick, R., and Nussenzweig, V., 1970, A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes, J. Exp. Med. 132:702–720.
Bias, W. B., Santos, G. W., Burke, P. J., Mullins, G. M., and Humphrey, R. L., 1972, Cytotoxic antibody on normal human serums reactive with tumor cells from acute lymphocytic leukemia, Science 178:304–306.
Blank, K. J., Freedman, H. A., and Lilly, F., 1976, T-lymphocyte response to Friend virus-induced tumor cell lines in mice of strains congenic at H-2, Nature (London) 260:250–252.
Block, J. B., Haynes, H. A., Thompson, W. L., and Neiman, P. E., 1969, Delayed hypersensitivity in chronic lymphocytic leukemia, J. Nat. Cancer Inst. 42:973–980.
Bolognesi, D. P., 1974, Structural components of RNA tumor viruses, in Advances in Virus Research, Vol. 19 (M. Lauffer, F. B. Bang, K. Maramorosch, and K. M. Smith, eds.), pp. 315–359, Academic Press, New York.
Bonmassar, E., and Cudkowicz, G., 1976, Suporession of allogeneic lymphomas in spleens of irradiated mice: Importance of the D end of the complex, J. Immunol. 117:697–700.
Bonmassar, E., Bonmassar, A., Vadlamudi, S., and Goldin, A., 1970, Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug, Proc. Nat. Acad. Sci. U.S.A. 66:1089–1095.
Bonnard, G. D., and Herberman, R. B., 1975, Suppression of lymphocyte proliferative response by murine lymphoma cells, in Immune Recognition (A. S. Rosenthal, ed.), pp. 817–828, Academic Press, New York.
Bonnard, G. D., Manders, E. K., Campbell, D. A., Jr., Herberman, R. B., and Collins, M. J., Jr., 1976, Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition, J. Exp. Med. 143:187–205.
Borella, L., and Sen, T. A., 1973, T-cell surface markers on lymphoblasts from acute lymphocytic leukemia, J. Immunol. 3:1257–1260.
Bouroncle, B. A., Clausen, K. P., and Aschenbrand, J. F., 1969, Studies of the delayed response of phytohemagglutinin (PHA) stimulated lymphocytes in 25 chronic lymphatic leukemia patients before and during therapy, Blood 34:166–178.
Boyse, E. A., and Old, L. J., 1969, Some aspects of normal and abnormal cell surface genetics, Annu. Rev. Genet. 3:269–301.
Boyse, E. A., Old, L. J., and Luell, S., 1963, Antigenic properties of experimental leukemias. II. Immunological studies in vivo with C57BL/6 radiation-induced leukemias, J. Nat. Cancer Inst. 31:987.
Braylan, R., Variakojis, D., and Yachnin, S., 1975, The Sézary syndrome lymphoid cell: Abnormal surface properties and mitogen responsiveness, J. Haematol. 31:553–564.
Broder, S., Humphrey, R., Durm, M., Blackman, M., Meade, B., Goldman, C., Strober, W., and Waldmann, T., 1975, Impaired synthesis of polyclonal (nonparaprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma, N. Engl. J. Med. 293:887–892.
Broome, J. D., Zucker-Franklin, D., Weiner, M. S., Bianco, C., and Nussenzweig, V., 1973, Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary’s syndrome: Morphologic and immunologic studies, Clin. Immunol. Immunopathol. 1:319–329.
Brouet, J. C., Flandrin, G., and Seligmann, M., 1973, Indications of the thymus-derived nature of the proliferative cells in six patients with Sézary’s syndrome, N. Engl. J. Med. 289:341–344.
Brown, G., Capellaro, D., and Greaves, M., 1975a, Leukemia-associated antigens in man, J. Nat. Cancer Inst. 55:1281–1289.
Brown, G., Hogg, N., and Greaves, M., 1975b, Candidate leukemia-specific antigen in man, Nature (London) 258:454–456.
Ceglowski, W. S., and Friedman, H., 1973, Virus Tumorigenesis and Immunogenesis, p. 414, Academic Press, New York.
Chandra, R. K., 1972, Serum immunoglobulin levels in children with acute lymphoblastic leukemia and their mothers and sibs, Arch. Dis. Child. 47:618–621.
Char, D. H., Lepourhiet, A., Leventhal, B. G., and Herberman, R. B., 1973, Cutaneous delayed hypersensitivity responses to tumor associated and other antigens in acute leukemia, Int. J. Cancer 12:409–419.
Cheema, A. R., and Hersh, E. M., 1971, Patient survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis, Cancer 28:857–862.
Children’s Cancer Study Group A, 1973, BCG in the treatment of acute lymphoblastic leukemia, Proc. Am. Assoc. Cancer Res. 14:45.
Cikes, M., and Friberg, S., Jr., 1971, Expression of H-2 and Moloney leukemia virus-determined cell-surface antigens in synchronized cultures of a mouse cell line, Proc. Nat. Acad. Sci. U.S.A. 68:566–569.
Cikes, M., and Klein, G., 1972, Quantitative studies of antigen expression in cultured murine lymphoma cells. I. Cell-surface antigens in “synchronous” cultures, J. Nat Cancer Inst. 49:1599–1606.
Cikes, M., Friberg, J. R., and Klein, G., 1973, Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured Moloney leukemias, J. Nat. Cancer Inst. 50:347–362.
Colnaghi, M. I., and Delia Porta, G., 1973, Evidence for virus-related and unrelated antigens on murine lymphomas induced by chemical carcinogens, J. Nat. Cancer Inst. 50:173–180.
Davies, D. A. L., Boyse, E. A., Old, L. J., and Stocken, E., 1967, Mouse isoantigens: Separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histo-compatibility antigen by column chromatography. J. Exp. Med. 125:549–562.
Davies, D. A. L., Baugh, V. S. G., Buckham, S., and Manstone, A. J., 1974, Separation of the specific antigen of a mouse lymphoma from histocompatibility antigens, Eur. J. Cancer 10:781–786.
Del Villano, B., Nave, B., Crocker, B., Lerner, R., and Dixon, F., 1975, The oncornavirus glycoprotein gp 69/71: A constituent of the surface of normal and malignant thymocytes, J. Exp. Med. 141:172–187.
Dickler, H. B., and Kunkel, H. G., 1972, Interaction of aggregated γ-globulin with B lymphocytes, J. Exp. Med. 136:191–201.
Dickler, H. B., Siegal, F. P., Bentwich, Z. H., and Kunkel, H. G., 1973, Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocyte leukemia, Clin. Exp. Immunol. 14:97–106.
Djeu, J. Y., Glaser, M., Kirchner, H., Huang, K. Y., and Herberman, R. B., 1974, The effect of specific anti-rat thymocyte serum on cell-mediated tumor immunity and other lymphocyte functions, Cell. Immunol. 12:164–169.
Doherty, P. C., Blanden, R. V., and Zinkernagel, R. M., 1976, Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: Implications for H-antigen diversity, Transplant. Rev. 29:89–124.
Doré, J. F., Motta, R., Markoley, L., Hrsak, I., Colas de la Nove, H., Seman, G., de Vassal, F., and Mathé, G., 1967, New antigens in leukemic cells, and antibody in the serum of leukemic patients, Lancet 2:1396–1398.
Dupuy, J. M., Kourilsky, F. M., Fradelizzi, D., Feingold, N., Jacquillat, C., Bernard, J., and Dausset, J., 1971, Depression of immunologic reactivity of patients with acute leukemia, Cancer 27:323–331.
Edelson, R. L., Kirkpatrick, C. H., Shevach, E. M., Schein, P. S., Smith, R. W., Green, I., and Lutzner, M. A., 1974, Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes: Morphologic and functional studies, Ann. Intern. Med. 80:685–706.
Epstein, L. B., and Knight, R. A., 1975a, Studies on mouse Moloney virus-induced tumors: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibodymediated cytotoxicity, Br. J. Cancer 31:499–512.
Epstein, L. B., and Knight, R. A., 1975b, Studies on mouse Moloney virus-induced tumors: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement-dependent antibody-mediated cytotoxicity, Br. J. Cancer 31:513–523.
Essex, M., 1975, The immune response to oncornavirus infections, in Viruses, Evolution and Cancer (E. Kurstak and K. Maramorosch, eds.), pp. 513–548, Academic Press, New York.
Essex, M., Cotter, S. M., Hardy, W. D., Jr., Hess, P., Jarrett, W., Jarrett, O., Mackey, L., Laird, H., Perryman, L., Olsen, R. G., and Yohn, D. S., 1975a, J. Nat. Cancer Inst. 55:463–467.
Essex, M., Jakowski, R. M., Hardy, W. D., Jr., Cotter, S. M., Hess, P., and Sliski, A., 1975b, Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households, J. Nat. Cancer Inst. 54:637–641.
Essex, M., Sliski, A., Cotter, S. M., Jakowski, R. M., and Hardy, W. D., Jr., 1975c, Immunosurveillance of naturally occurring feline leukemia, Science 190:790–792.
Feldman, J. D., 1973, Immunological enhancement: A study of blocking antibodies, Adv. Immunol. 15:167–214.
Fenyö, E. M., and Klein, G., 1976, Independence of Moloney virus-induced cell-surface antigen and membrane-associated virion antigens in immunoselected lymphoma sublines, Nature (London) 260:355–357.
Fenyö, E., Grundner, G., and Klein, E., 1974, Virus-associated surface antigens on L cells and Moloney lymphoma cells, J. Nat. Cancer Inst. 52:743–750.
Ferrer, J. F., 1973, Cell-surface and virion-envelope antigens shared by radiation leukemia virus (Rad LV) and other murine C-type viruses, Int. J. Cancer 12:378–386.
Ferrer, J., and Gibbs, F., 1969, Concomitant loss of specific cell-surface antigen and demonstrable type-C virus particles in lymphomas induced by radiation leukemia virus in rats, J. Nat Cancer Inst. 43:1317–1330.
Ferrer, J., and Kaplan, H., 1968, Antigenic characteristics of lymphomas induced by radiation leukemia virus in mice and rats, Cancer Res. 28:2522–2528.
Fink, M. A., Malmgren, R. A., Karon, M., and Orr, H. C., 1965, Immunofluores-cence studies in human leukemia, in Methodological Approaches to the Study of Leukemias, pp. 187–196, The Wistar Institute Press, Philadelphia.
Freedman, A. H., Lilly, F., and Steeves, R., 1975, Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice, J. Exp. Med. 142:1365–1375.
Freeman, C. B., Harris, R., Geary, C. G., Leyland, M. J., Maclver, J. E., and Delamore, I. W., 1973, Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia, Br. Med. J. 4:571–573.
Frey-Wettstein, M., and Hays, E. F., 1970, Immune response in preleukemic mice, Infect. Immun. 2:398–403.
Fridman, W. H., and Kourilsky, F. M., 1969, Stimulation of lymphocytes by autologous leukemic cells in acute leukemia, Nature (London) 224:277–279.
Friedman, H., Specter, S., Kamo, I., and Kateley, J., 1976, Immunosuppressive factors from tumor cells, Ann. N.Y. Acad. Sci. 276:417–430.
Fu, S. M., Winchester, R. J., and Kunkel, H. G., 1975, The occurrence of the HL-B alloantigens on the cells of unclassified acute lymphoblastic leukemias, J. Exp. Med. 142:1334–1338.
Gallagher, M. T., Lotzova, E., and Trentin, J. J., 1976, Genetic resistance to marrow transplantation as a leukemia defense mechanism, Biomedicine 25:1–3.
Gelderblom, H., Bauer, H., and Graf, T., 1972, Cell-surface antigens induced by avian RNA tumor viruses: Detection by immunoferritin technique, Virology 47:416–425.
Gilden, R. V., Oroszlan, S., and Huebner, R. J., 1971, Coexistence of intraspecies and interspecies specific antigenic determinants on the major structural polypeptide of mammalian C-type viruses, Nature New Biol. 231:107–108.
Glaser, M., and Herberman, R. B., 1974, The effect of immunoregulatory α-globulin (IRA) on in vitro proliferation of rat lymphocytes to syngeneic Gross virus-induced lymphoma, J. Nat. Cancer Inst. 53:1767–1769.
Glaser, M., and Herberman, R. B., 1976, Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma, J. Nat. Cancer Inst. 56:1211–1215.
Glaser, M., Kirchner, H., and Herberman, R. H., 1975, Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors, Int. J. Cancer 16:384–393.
Glaser, M., Lavrin, D. H., and Herberman, R. B., 1976a, In vivo protection against syngeneic Gross virus-induced lymphoma in rats: Comparison with in vitro studies of cell-mediated immunity, J. Immunol. 116:1507–1511.
Glaser, M., Ting, C. C., and Herberman, R. B., 1976b, In vitro inhibition of cell-mediated cytotoxicity against syngeneic Friend virus-induced leukemia by immunoregulatory alpha globulin, J. Nat. Cancer Inst. 55:1477–1479.
Gomard, E., Duprez, V., Henin, Y., and Levy, J. P., 1976, An H2 region product is determinant in the immune cytolysis of syngeneic tumor cells by anti-MSV T lymphocytes, Nature (London) 260:707–709.
Gooch, W. M., and Fernbach, D. J., 1971, Immunoglobulins during the course of acute leukemia in children, Cancer 28:984–990.
Grant, J. P., Bigner, D. D., Fischinger, P. J., and Bolognesi, D. P., 1974, Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas, Proc. Nat. Acad. Sci. U.S.A. 71:5037–5041.
Greaves, M. F., and Brown, G., 1973, A human B-lymphocyte-specific antigen, Nature New Biol. 246:116–118.
Greaves, M. F., Brown, G., Rapson, N. T., and Lister, J. A., 1975, Antisera to acute lymphoblastic leukemia cells, Clin. Immunol. Immunopathol. 4:67–84.
Greenberg, R., and Zatz, M., 1975, Spontaneous AKR lymphoma with T-and B-cell characteristics, Nature (London) 257:314–316.
Greenspan, I., Brown, E. R., and Schwartz, S. O., 1963, Immunologically specific antigens in leukemic tissues, Blood 21:717–727.
Gutterman, J. U., Hersh, E. M., Freireich, E. J., Rossen, R. D., Butler, W. T., McCredie, K. B., Bodey, G. P. Sr., Rodriguez, V., and Mavligit, G. M., 1973a, Cell-mediated and humoral response to acute leukemia cells and soluble leukemia antigen—Relationship to immunocompetence and prognosis, Nat. Cancer Inst. Monogr. 37:153–156.
Gutterman, J. U., Rossen, R. D., Butler, W. T., McCredie, K. B., Bodey, G. P., Freireich, E. J., and Hersh, E. M., 1973b, Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia, N. Engl. J. Med. 288:169–173.
Gutterman, J. U., Mavligit, G., Burgess, M. A., McCredie, K. B., Hunter, C., Freireich, E. J., and Hersh, E. M., 1974a, Brief communication: Immunodiagnosis of acute leukemia: Detection of residual disease, J. Nat. Cancer Inst. 53:389–392.
Gutterman, J. U., Rodriguez, V., Mavligit, G., Burgess, M. A., Hersh, E. M., McCredie, K. B., Reed, R., Smith, T., Bodey, G. P., Sr., and Freireich, E. J., 1974b, Chemo-immunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G., Lancet 2:1405–1409.
Gutterman, J. U., Mavligit, G., Rossen, R., Butler, W. T., McBride, C. M., McCredie, K. B., Freireich, E. J., and Hersch, E. M., 1975, Tumor immunity in human acute leukemia and solid tumors: A multifaceted study of cell-mediated and humoral response to autologous tumor cells and soluble tumor antigen and the correlation with prognosis, in Immunological Aspects of Neoplasia (Univ. Texas M.D. Anderson Hosp., 26th Annual Symposium on Fundamental Cancer Res.), pp. 343–365, Williams & Wilkins, Baltimore, Maryland.
Hammerling, U., Aoki, T., De Harven, E., Boyse, E. A., and Old, L. J., 1968, Use of hybrid antibody with an anti-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy, J. Exp. Med. 128:1461–1473.
Hanna, M. G., Tennant, R. W., and Coggin, J. H., Jr., 1971, Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and on plasma cell tumor, Proc. Nat. Acad. Sci. U.S.A. 68:1748–1752.
Haran-Ghera, N., and Peled, A., 1973, Thymus and bone marrow derived lymphatic leukemia in mice, Nature (London) 241:396–398.
Harris, J. E., and Stewart, T. H. M., 1972, Recovery of mixed lymphocyte reactivity (MLR) following cancer chemotherapy in man, in Proceedings of the Sixth Leucocyte Culture Conference (M. R. Schwarz, ed.), pp. 555–559, Academic Press, New York.
Harris, R., Viza, D., Todd, R., Phillips, J., Sugar, R., Jennison, R. F., Marriott, G., and Gleeson, M. H., 1971, Detection of human leukaemia-associated antigens in leukaemic serum and normal embryos, Nature (London) 233:556–557.
Henderson, E. S., and Leventhal, B., 1972, Immunotherapy of leukemia, in Cancer Chemotherapy II, The 22nd Hahnemann Symposium (I. Brodsky, S. B. Kahn, and J. H. Moger, eds.), pp. 327–345, Grune & Stratton, New York.
Herberman, R. B., 1969, Studies on the specificity of human cytotoxic antibody reactive with cultures of lymphoid cells, J. Nat. Cancer Inst. 42:69–75.
Herberman, R. B., 1972, Serological analysis of cell surface antigens of tumors induced by murine leukemia virus, J. Nat. Cancer Inst. 48:265–271.
Herberman, R. B., 1974, Cell-mediated immunity to tumor cells, in Advances in Cancer Research, Vol. 19 (G. Klein and S. Weinhouse, eds.), pp. 207–263, Academic Press, New York.
Herberman, R. B., 1977, Cell-mediated immunity to leukemia associated antigens in experimental models and in man, in Modern Trends in Human Leukemia II (R. Neth, R. C., Gallo, K. Mannweiler, and W. C. Moloney, eds.), pp. 195–206, J. F. Lehmanns Verlag, Munich.
Herberman, R. B., and Fahey, J. L., 1968, Cytotoxic antibody in Burkitt’s tumor and normal human serum reactive with cultures of lymphoid cells, Proc. Soc. Exp. Biol. Med. 127:938–940.
Herberman, R. B., and Nam, J. M., 1971, Cytotoxic antibody reactive with cultures of lymphoid cells: Occurrence in disease and normal human sera, J. Nat. Cancer Inst. 47:489–494.
Herberman, R. B., and Oren, M. E., 1971, Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response, J. Nat. Cancer Inst. 46:391–396.
Herberman, R. B., Rosenberg, E. B., Halterman, R. H., McCoy, J. L., and Leventhal, B. G., 1972, Cellular immune reactions to human leukemia, Nat. Cancer Inst. Monogr. 35:259–266.
Herberman, R. B., Aoki, T., Nunn, M., Lavrin, D. H., Soares, N., Gazdar, A., Holden, H., and Chang, K. S. S., 1974a, Specificity of 51Cr-release cytotoxicity by lymphocytes immune to murine sarcoma virus, J. Nat. Cancer Inst. 53:1103–1111.
Herberman, R. B., McCoy, J. L., and Levine, P. H., 1974b, Immunological reactions to tumor-associated antigens in Burkitt’s lymphoma and other lymphomas, Cancer Res. 34:1222–1227.
Herberman, R. B., Char, D. H., Oldham, R. K., and Leventhal, B. G., 1975a, The prognostic value of studies of specific cell-mediated immunity in acute leukemia, in Advances in the Biosciences 14. Workshop on Prognostic Factors in Human Leukemia (T. M. Fliedner and S. Perry, eds.), pp. 431-440, Friedr. Vieweg und Sohn, Braunschweig, West Germanv.
Herberman, R. B., Char, D., Oldham, R., Levine, P., Leventhal, B. G., McCoy, J. L., Ho, H. C., and Chau, J. C. W., 1975b, Cell-mediated immunity in human adult leukemia, in Comparative Leukemia Research, Leukemogenesis, 1973 (Y. Ito and R. M. Satcher, eds.), pp. 649–656, University of Tokyo Press, Tokyo; Karger, Basel.
Herberman, R. B., Lepourhiet, A., Hollinshead, A., Char, D., McCoy, J. L., and Leventhal, B. G., 1975c, Humoral and cell-mediated immunity in human acute leukemia, in Immunological Aspects of Neoplasia, pp. 423–438, Williams & Wilkins, Baltimore, Maryland.
Herberman, R. B., Nunn, M. E., Holden, H. T., and Lavrin, D. H., 1975d, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells, Int. J. Cancer 16:230–239.
Herberman, R. B., Nunn, M. E., and Lavrin, D. H., 1975e, Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity, Int. J. Cancer 16:216–229.
Herberman, R. B., Ting, C. C., Holden, H. T., Glaser, M., and Lavrin, D., 1975f, Dynamics of immune responses to tumor associated antigens, in Proceedings of the XIth International Cancer Congress (P. Bucalossi, U. Veronesi, and N. Cassenelli, eds.), pp. 258-263, Excerpta Medica, Amsterdam.
Hersey, P., MacLennan, I. C. M., Campbell, A. C., Harris, R., and Freeman, C. B., 1973, Cytotoxicity against human leukemic cells. I. Demonstration of antibody-dependent lymphocyte killing of human allogeneic myoblasts, Clin. Exp. Immunol. 14:159–166.
Hersh, E. M., and Oppenheim, J. J., 1967, Inhibition of in vitro lymphocyte transformation during chemotherapy in man, Cancer Res. 27:98–109.
Hersh, E. M., Whitecar, J. P., Jr., McCredie, K. B., Bodey, G. P., Sr., and Freireich, E. J., 1971, Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia, N. Engl. J. Med. 285:1211–1216.
Hersh, E. M., Gutterman, J. U., and Mavligit, G., 1973, Immunotherapy of Cancer in Man. Scientific Basis and Current Status, p. 141, Charles C. Thomas, Springfield, Illinois.
Hersh, E. M., Gutterman, J. U., Mavligit, G., McCredie, K. B., Bodey, G. P., Sr., and Freireich, E., 1975, Immunocompetence, immunological deficiency, and prognosis of established cancer, in Immunological Aspects of Neoplasia (Univ. Texas M.D. Anderson Hosp., 26th Annual Symposium on Fundamental Cancer Res.), pp. 293–303, Williams & Wilkins, Baltimore, Maryland.
Hilberg, R. W., Balcerzak, S. P., and LoBuglio, A. F., 1973, A migration inhibition-factor assay for tumor immunity in man, Cell. Immunol. 7:152–158.
Hilgers, J., Decleve, A., Galesloot, J., and Kaplan, H., 1974, Murine leukemia virus group-specific antigenic expression in AKR mice, Cancer Res. 34:2553–2561.
Holden, H. T., Kirchner, H., and Herberman, R. B., 1975, Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge, J. Immunol 115:327–331.
Holden, H. T., Haskill, J. S., Kirchner, H., and Herberman, R. B., 1976, Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors, J. Immunol. 177:440–446.
Holden, H. T., Landolfo, S., and Herberman, R. B., 1977, T-cell dependent reactivity against tumor-associated antigens on allogeneic target cells, Transplant. Proc. 9:1149–1152.
Hollinshead, A. C., and Herberman, R. B., 1975, Identification and characterization: Cell-membrane antigens associated with the blast phase of human acute leukemia, in Comparative Leukemia Research Leukemogenesis, 1973 (Y. Ito and R. M. Sutcher, eds.), pp. 339–348, University of Tokyo Press, Tokyo; Karger, Basel.
Houchens, D. P., Bommassar, E., Gaston, M. R., Kende, M., and Goldin, A., 1976, Drug-mediated immunogenic changes of virus-induced leukemia in vivo, Cancer Res. 36:1347–1352.
Huebner, R. J., and Todaro, G. J., 1969, Oncogenesis of RNA tumor viruses as determinants of cancer, Proc. Nat. Acad. Sci. U.S.A. 64:1087–1094.
Huebner, R., Kelloff, G., Sarma, P., Lane, W., Turner, H., Gilden, R. V., Oroszlan, S., Meier, H., Myers, D. D., and Peters, R. L., 1970, Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: Implications for ontogenesis, Proc. Nat. Acad. Sci. U.S.A. 67:366–376.
Hunsmann, G., Claviez, M., Moennig, U., Schwarz, H., and Shafer, W., 1976, Properties of mouse leukemia viruses. X. Occurrence of viral structural antigens on the cell surface as revealed by a cytotoxicity test, Virology 69:157–168.
Ihle, J. N., Yurconic, M., Jr., and Hanna, M. G., Jr., 1973, Autogenous immunity to endogenous RNA tumor virus: Radioimmune precipitation assay of mouse serum antibody levels, J. Exp. Med. 138:194–208.
Ikeda, H., Pincus, T., Yoshiki, T., Strand, M., August, J. T., Boyse, E. A., and Mellors, R. C., 1974, Biological expression of antigenic determinants of murine leukemia virus proteins gp 69/71 and p30, J. Virol. 14:1274–1280.
Insel, R., Melewicz, F. M., Iavia, M., and Blach, C. M., 1975, Morphology surface markers and in vitro responses of a human leukemic T cell, Clin. Immunol. Immunopathol. 4:382–391.
Ioachim, H., Keller, S., Dorsett, B., and Pearse, A., 1974, Induction of partial immunologic tolerance in rats and progressive loss of cellular antigenicity in Gross virus lymphoma, J. Exp. Med. 139:1382–1394.
Ishii, Y., Koshiba, H., Veno, H., Maeyama, I., Takami, T., Ishibashi, F., and Kikuchi, K., 1975, Characterization of human B-lymphocyte-specific antigens, J. Immunol. 114:466–469.
Ishimoto, A., and Ito, Y., 1972, Presence of antibody against mouse fetal antigen in the sera of C57BL/6 mice immunized with Rauscher leukemia, Cancer Res. 32:2333–2337.
Jondal, M., Holm, G., and Wigzell, H. J., 1972, Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells, J. Exp. Med. 136:207–215.
Joseph, R. R., Belpomme, D., and Mathé, G., 1976, Short Communication: Increase in “null” cells in acute lymphocytic leukemia in remission on long-term immunotherapy, Br. J. Cancer 33:567–570.
Kagan, R. A., and Johnson, R. E., 1967, Evaluation of therapy in chronic lymphocytic leukemia using in vitro lymphocyte transformation, Radiology 88:352–359.
Kennel, S., and Feldman, J., 1976, Distribution of viral glycoprotein gp69/71 on cell surfaces of producer and nonproducer cells, Cancer Res. 36:200–207.
Kersey, J., Nesbit, M., and Luckasen, J., 1974, Acute lymphoblastic leukemic and lymphoma cells with thymus-derived (T) markers, Mayo Clinic Proc. 49:584–587.
Kiessling, R., Klein, E., and Wigzell, H., 1975a, “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5:112–117.
Kiessling, R., Klein, E., Pross, H., and Wigzell, H., 1975b, “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell, Eur. J. Immunol. 5:117–121.
Kiessling, R., Petranyi, G., Klein, G., and Wigzell, H., 1975c, Genetic variation of in vitro cytolytic activity and in vivo rejection potential of nonimmunized semisyngeneic mice against a mouse lymphoma line, Int. J. Cancer 15:933–940.
Kirchner, H., Glaser, M., Holden, H. T., Fernbach, B. R., and Herberman, R. B., 1977, Suppressor cells in tumor-bearing mice and rats, Biomedicine 24:371–373.
Klein, G., Klein, E., and Haughton, G., 1966, Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus, J. Nat. Cancer Inst. 36:607–621.
Klein, G., Steiner, M., Wiener, F., and Klein, E., 1974, Human leukemia-associated anti-nuclear reactivity, Proc. Nat. Acad. Sci. U.S.A. 71:685–689.
Klouda, P. T., Lawler, S. D., Powles, R., Oliver, R. T. D., and Grant, C. K., 1975, HL-A antibody in patients with acute myelogenous leukemia treated by immunotherapy, Transplantation 19:245–250.
Knight, R. A., Mitchison, N. A., and Shellam, G. R., 1975, Studies on a Gross-virus-induced lymphoma in the rat. II. The role of cell-membrane associated and serum p30 antigen in the antibody and cell-mediated response, Int. J. Cancer 15:417–428.
Kumar, V., Trentin, J., and Cudkowicz, G., 1976, Discussion, Ann. N.Y. Acad. Sci. 276:39–44.
Kurth, R., and Bauer, H., 1972, Common tumor-specific surface antigens on cells of different species transformed by avian RNA tumor viruses, Virology 49:145–149.
Kurth, R., and Bauer, H., 1973, Avian oncornavirus-induced tumor antigens of embryonic and unknown origin, Virology 56:496–504.
Kuzumaki, N., Takeichi, N., Sendo, F., Kodama, T., and Kobayashi, H., 1973, Correlation between various cell-surface antigens induced by mouse leukemia virus in the rat: Serological analysis, Int. J. Cancer 11:575–585.
Lamon, E. W., 1974, The immune response to virally determined tumor associated antigens, Biochim. Biophys. Acta 355:149–176.
Larson, D. L., and Tomlinson, L. J., 1953, Quantitative antibody studies in man. III. Antibody response in leukemia and other malignant lymphomas, J. Clin. Invest. 32:317–321.
Law, L. W., and Appella, E., 1973, Immunologic properties of solubilized tumour antigen from an RNA virus-transformed neoplasm, Nature (London) 243:83–87.
Lay, W. H., and Nussenzweig, V., 1968, Receptors for complement on leukocytes, J. Exp. Med. 128:991–1007.
Leclerc, J. C., Levy, J. P., Varet, B., Oppenheim, S., and Senik, A., 1970, Antigenic analysis of L strain cells: A new murine leukemia-associated antigen, “L,” Cancer Res. 30:2073–2079.
Lee, J., and Ihle, J., 1975, Autogenous immunity to endogenous RNA tumor virus: Reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses, J. Nat. Cancer Inst. 55:831–838.
Lerner, R. A., Oldstone, M. B., and Cooper, N. R., 1971, Cell-cycle dependent immune lysis of Moloney virus-transformed lymphocytes: Presence of viral antigen, accessibility to antibody, and complement activation, Proc. Nat. Acad. Sci. U.S.A. 68:2584–2588.
Leventhal, B. G., Halterman, R. H., Rosenberg, R. B., and Herberman, R. B., 1972, Immune reactivity of leukemic patients to autologous blast cells, Cancer Res. 32:1820–1825.
Leventhal, B. G., LePourhiet, A., Halterman, R. H., Henderson, E. S., and Herberman, R. B., 1973, Immunotherapy in previously treated acute lymphatic leukemia, Nat. Cancer Inst. Monogr. 39:177–187.
Leventhal, B. G., Cohen, P., and Triem, S. C., 1974, Effect of chemotherapy on the immune response in acute leukemia, Israel J. Med. Sci. 10:866–887.
Levy, J. P., Leclerc, J. C., Varet, B., and Oppenheim, E., 1968, Study of the antigenic specificity of Graffileukemic cells, J. Nat. Cancer Inst. 41:743–750.
Levy, M. H., and Wheelock, E. F., 1975, Impaired macrophage function in Friend virus leukemia: Restoration by statolon, J. Immunol. 114:962–965.
Lieberman, M., and Kaplan, H. S., 1959, Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice, Science 130:387–388.
Lilly, F., and Steeves, R., 1974, Antigens of murine leukemia viruses, Biochim. Biophys. Acta 355:105–118.
Lin, P. S., and Hsu, C. C. S., 1976, Human leukaemic T cells with complement receptors, Clin. Exp. Immunol. 23:209–213.
Linker-Israeli, M., and Haran-Ghera, N., 1975, Cell-surface markers on murine lymphomas, Immunochemistry 12:585–588.
MacLennan, I. C. M., Gale, D. G. L., and Wood J., 1975, Resistance of certain leukaemic myeloblasts to immunological attack, Int. J. Cancer 15:995–999.
Mann, D. L., Halterman, R., Rogentine, G. N., and Leventhal, B. G., 1971, Detection of an acute leukemia-associated antigen, Science 174:1136–1137.
Mann, D. L., Ulmer, C., Lepourhiet, A., Leventhal, B., and Halterman, R., 1974, Studies on the immunologic reactivity of sera from acute leukemia patients, Prog. Exp. Tumor Res. 19:102–109.
Mann, D. L., Leventhal, B., and Halterman, R., 1975, Brief communication: Human antisera detecting leukemia-associated antigens on autochthonous tumor cells, J. Nat. Cancer Inst. 54:345–347.
Martyre, M. C., Halle-Pannenko, O., and Jolies, P., 1973, Characterization and partial purification of normal and tumor-associated transplantation antigens of Rauscher leukemia cells, Eur. J. Cancer 9:757–761.
Maruyama, K., Dmochowski, L., Bowen, J. M., and Hales, R. L., 1968, Studies of human leukemia and lymphoma cells by membrane immunofluorescence and mixed hemadsorption tests, Texas Rep. Biol. Med. 26:545–565.
Mathé, G., Delgado, M., Pouillart, P., Belpomme, D., Joseph, R., Schwarzenberg, L., Schneider, M., Cattan, A., Musset, M., Misset, J. L., and Jasmin, C., 1976, 1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy, Cancer Immun. Immunother. 1:77–86.
McKelvey, E., and Carbone, P. P., 1965, Serum immune globulin concentrations in acute leukemia during intensive chemotherapy. Cancer 18:1292–1297.
Medical Research Council, 1971, Treatment of acute lymphoblastic leukemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen (Concord trial), Br. Med. J. 4:189–194.
Metcalf, D., and Moulds, R., 1967, Immune responses in preleukemic and leukemic mice. Int. J. Cancer 2:53–58.
Metzgar, R. S., Mohanakumar, T., Green, R. W., Miller, D. S., and Bolognesi, D. P., 1974, Human leukemia antigens: Partial isolation and characterization, J. Nat. Cancer Inst. 52:1445–1453.
Metzgar, R. S., Mohanakumar, T., and Miller, D. S., 1975, Membrane-bound immunoglobulins on human leukemic cells: Evidence for humoral immune responses of patients to leukemia-associated antigens, J. Clin. Invest. 56:331–338.
Metzgar, R. S., Mohanakumar, T., and Bolognesi, D. P., 1976a, Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components, J. Exp. Med. 143:47–63.
Metzgar, R. S., Mohanakumar, T., and Bolognesi, D. P., 1976b, Antigenic relationships between murine, feline and primate RNA tumor viruses and membrane antigens of human leukemic cells, in Comparative Leukemia Research 1975, Bibl. Haematol., No. 43 (J. Clemmesen and D. S. Yohn, eds.), pp. 549–554, Karger, Basel.
Minowada, J., Ohnuma, T., and Moore, G. E., 1972, Brief communication: Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes, J. Nat. Cancer Inst. 49:891–895.
Mitchell, M. S., Mokyr, M. M., Aspnes, G. T., and Mclntosh, S., 1973, Cytophilic antibodies in man, Ann. Intern. Med. 79:333–339.
Mohanakumar, T., Metzgar, R. S., and Miller, D. S., 1974, Human leukemia cell antigens: Serologie characterization with xenoantisera, J. Nat. Cancer Inst. 52:1435–1444.
Mori, W., Asakawa, H., and Taguchi, T., 1975a, Antiplacental ferritin antiserum for cancer diagnosis, Ann. N.Y. Acad. Sci. 259:446–449.
Mori, W., Asakawa, H., and Taguchi, T., 1975b, Antiserum against leukemia cell ferritin as a diagnostic tool for malignant neoplasms, J. Nat. Cancer Inst. 55:513–518.
Nagaya, H., 1973, Thymus function in spontaneous lymphoid leukemia. II. In vitro response of “preleukemic” and leukemic thymus cells to mitogens, J. Immunol. 111:1052–1061.
Nowell, P. C., 1960, Phytohemagglutinin, an initiator of mitosis in cultures of normal human leukocytes, Cancer Res. 20:462–470.
Nowinski, R. C., and Kaehler, S. L., 1974, Antibody to leukemia virus. Widespread occurrence in inbred mice, Science 185:869–871.
Nowinski, R. C., and Klein, P. A., 1975, Anomalous reactions of mouse alloantisera with cultured tumor cells. II. Cytotoxicity is caused by antibodies to leukemia viruses, J. Immunol. 115:1261–1268.
Nowinski, R. D., and Peters, E., 1973, Cell surface antigens associated with murine leukemia virus: Definition of the Gl and Gl antigenic systems, J. Virol. 12:1104–1117.
Nunn, M. E., Djeu, J. Y., Glaser, M., Lavrin, D. H., and Herberman, R. B., 1976, Natural cy to toxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma, J. Nat. Cancer Inst. 56:393–399.
Obata, Y., Ikeda, H., Stocken, E., and Boyse, E., 1975, Relation of Gix antigen of thymocytes to envelope glycoproteins of murine leukemia virus, J. Exp. Med. 141:188–197.
Odaka, T., 1975, Strain-dependent expression of endogenous mouse-tropic leukemia viruses in chemically induced murine leukemias, Int. J. Cancer 16:622–628.
Oehler, J. R., Campbell, D. A., Jr., and Herberman, R. B., 1977, In vitro inhibition of lymphoproliferative responses to tumor-associated antigens and of lymphoma cell proliferation by rat splenic macrophages, Cell. Immunol. 28:355–370.
Old, L. J., Boyse, E. A., and Stocken, E., 1964, Typing of mouse leukemias by serological methods, Nature (London) 201:777–779.
Old, L., Boyse, E. A., and Stocken, E., 1965, The G (Gross) leukemia antigen, Cancer Res. 25:813–819.
Old, L. J., Stocken, E., Boyse, E. A., and Kim, J. H., 1968, Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro, J. Exp. Med. 127:523–540.
Oldham, R. K., Weiner, R. S., Mathé, G., Breard, J., Simmler, M. C., Carde, P., and Herberman, R. B., 1976, Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remission, Int. J. Cancer 17:326–377.
Opelz, G., Kiuchi, M., Takasugi, M., and Terasaki, P., 1975, Autologous stimulation of human lymphocyte subpopulations, J. Exp. Med. 142:1327–1333.
Oppenheim, J. J., Whang, J., and Frei, E., III, 1965, Immunologic and cytogenetic studies of chronic lymphocytic leukemic cells, Blood 26:121–132.
Oren, M. E., and Herberman, R. B., 1971, Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumor cells, Clin. Exp. Immunol. 9:45–56.
Ortaldo, J. R., Ting, C. C., and Herberman, R. B., 1974, Modulation of fetal antigen(s) in mouse leukemia cells, Cancer Res. 34:1366–1371.
Osserman, E. F., and Lawlor, D. P., 1966, Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia, J. Exp. Med. 124:921–952.
Pearson, G., Orr, T., Redmon, L., and Bergs, U., 1972, Membrane immunofluorescence studies on cells producing rat C-type virus particles, Int. J. Cancer 10:14–19.
Piessens, U., Schur, P., Maloney, W., and Churchill, W. H., 1973, Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases, N. Engl. J. Med. 288:176–180.
Poplack, D. G., Graw, R. G., Pomeroy, T. C., Henderson, E. S., and Leventhal, B. G., 1975, Chemotherapy (CT) vs. chemotherapy and immunotherapy (CT +IMT) in childhood acute lymphatic leukemia, Proc. Am. Assoc. Cancer Res. 16:230.
Powles, R. L., Balchin, L. A., Hamilton Fairley, G., and Alexander, P., 1971, Recognition of leukemia cells as foreign before and after autoimmunization, Br. Med. J. 1:486–489.
Powles, R. L., Crowther, D., Bateman, C. J. T., Beard, M. E. J., McElwain, T. J., Russell, J., Lister, T. A., Whitehouse, J. M. A., Wrigley, P. F. M., Pike, M., Alexander, P., and Hamilton Fairley, G., 1973, Immunotherapy for acute myelogenous leukemia, Br. J. Cancer 28:365–376.
Premkumar, E., Potter, M., Singer, P. A., and Sklar, M. D., 1975, Synthesis, surface deposition and secretion of immunoglobulins by Abelson virus-transformed lymphosarcoma cell lines, Cell 6:149–159.
Raff, M., 1969, Theta isoantigen as a marker of thymus-derived lymphocytes in mice, Nature (London) 224:378–379.
Ram, M. D., Kohn, R. R., and Novak, D., 1973, Immune response to sheep red cells in AKR mouse leukemia, Am. J. Pathol. 72:39–51.
Ram, M. D., Kohn, R. R., and Novak, D., 1974, Antigen distribution in AKR mouse leukemia, J. Nat. Cancer Inst. 52:1505–1514.
Reif, A. E., and Allen, J. M., 1964, The AKR thymic antigen and its distribution in leukemias and nervous tissue, J. Exp. Med. 120:413–433.
Roman, J. M., and Golub, E. S., 1976, Leukemia in AKR mice. I. Effects of Leukemic cells on antibody-forming potential of syngeneic and allogeneic normal cells, J. Exp. Med. 143:482–495.
Rosenberg, E. B., Herberman, R. B., Levine, P. H., Halterman, R. H., McCoy, J. L., and Wunderlich, J. R., 1972, Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins, Int. J. Cancer 9:648–658.
Rubin, A. D., Havemann, K., and Dameshek, W., 1969, Studies in chronic lymphocytic leukemia: Further studies of the proliferative abnormality of the blood lymphocyte, Blood 33:313–320.
Sacks, K. L., Olwen, Y. C., Mann, D. L., Simon, R., Johnson, G. E., Poplack, D. G., and Leventhal, B. G., 1975, A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia, Cancer Res. 35:3715–3720.
Santos, G. W., Mullins, G. M., Bias, W. B., Anderson, P. N., Graziano, K. D., Klein, D. L., and Burke, P. J., 1973, Immunologic studies in acute leukemia, Nat. Cancer Inst. Mongr. 37:69–75.
Sato, H., Boyse, E. A., Aoki, T., Iritani, C., and Old, L. J., 1973, Leukemia-associated transplantation antigens related to murine leukemia virus, J. Exp. Med. 138:593–606.
Scamps, R. A., Streeter, A. M., and O’Neill, B. J., 1971, Immunoglobulin levels in chronic lymphocytic leukemia, Med. J. Aust. 1:535–542.
Schieffer, C. A., Lichtenfeld, J. L., Wiernik, P. H., Mardiney, M. R., and Joseph, J. M., 1976, Antibody response in patients with acute nonlymphocytic leukemia, Cancer 37:2177–2182.
Schlossman, S., Chess, L., Humphrevs, R., and Strominger, J. L., 1976, Distribution of la-like molecules on the surface of normal and leukemic human cells, Proc. Nat. Acad. Sci. U.S.A. 73:1288–1292.
Schwarz, H., Hunsmann, G., Moennig, U., and Shäfer, W., 1976, Properties of mouse leukemia viruses. XL Immunoelectron microscopic studies on viral structural antigens on the cell surface, Virology 69:169–178.
Schweitzer, M., Melief, C. J. M., and Eijsvoogel, V. P., 1973, Failure to demonstrate immunity to leukemia-associated antigens by lymphocyte transformation in vitro, Int. J. Cancer 11:11–18.
Seligmann, M., Grabar, P., and Bernard, J., 1954, Mise en évidence dans le serum de sujets atteints de leucose aigüe d’anticorps precipitants anti-leucocytaires (Leucoprecipitaines), C. R. Heb. 239:1559–1561.
Sen, L., and Borella, L., 1973, Expression of cell surface markers on T and B lymphocytes after long-term chemotherapy of acute leukemia, Cell. Immunol. 9:84–95.
Sendo, F., Aoki, T., Boyse, E. A., and Buafo, C. K., 1975, Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL ♂ 1 cells, J. Nat. Cancer Inst. 55:603–609.
Shellam, G. R., and Knight, R. A., 1974, Antigenic inhibition of cell-mediated cytotoxicity against tumour cells, Nature (London) 252:330–332.
Shevach, E., Ellman, L., Davie, J. M., and Green, I., 1972a, L2C guinea pig lymphatic leukemia: A “B” cell leukemia, Blood 39:1–12.
Shevach, E. M., Herberman, R. B., Frank, M. M., and Green, I., 1972b, Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines, J. Clin. Invest. 51:1933–1938.
Shevach, E., Herberman, R., Lieberman, R., Frank, M. M., and Green, I., 1972c, Receptors for immunoglobulin and complement on mouse leukemias and lymphomas, J. Immunol. 108:325–328.
Shevach, E. M., Stobo, J. D., and Green, I., 1972d, Immunoglobulin and 9-bearing murine leukemias and lymphomas, J. Immunol. 108:1146–1151.
Shevach, E., Edelson, R., Frank, M., Lutzner, M., and Green, I., 1974, A human leukemia cell with both B and T cell receptors, Proc. Nat. Acad. Sci. U.S.A. 71:863–866.
Sklar, M. C., Shevach, E. M., Green, I., and Potter, M., 1975, Transplantation and preliminary characterization of lymphocyte surface markers of Abelson virus-induced lymphomas, Nature (London) 253:550–552.
Slettenmark-Wahren, B., and Klein, E., 1962, Cytotoxic and neutralization tests with serum and lymph node cells of isologous mice with induced resistance against Gross lymphomas, Cancer Res. 22:947–954.
Smith, J. L., Clein, G. P., Barker, C. R., and Collins, R. D., 1973, Characterization of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin, Lancet 1:74–76.
Smith, M., Browne, E., and Slungaard, A., 1973, The impaired responsiveness of chronic lymphatic leukemia lymphocytes to allogeneic lymphocytes, Blood 41:505–509.
Stackpole, C., Jacobson, J., and Lardis, M., 1974, Antigenic modulation in vitro fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of mouse leukemia cells and thymocytes, J. Exp. Med. 140:939–953.
Stockert, E., Old, L., and Boyse, E., 1971, The Gix system. A cell surface associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome, J. Exp. Med. 133:1334–1355.
Strand, M., and August, J. T., 1973, Structural proteins of oncogenic ribonucleic acid viruses. Interspec II, a new interspecies antigen, J. Biol. Chem. 248:5627–5633.
Strand, M., and August, J. T., 1974, Structural proteins of mammalian oncogenic RNA viruses: Multiple antigenic determinants of the major internal protein and envelope glycoprotein, J. Virol. 13:171–180.
Stück, B., Boyse, E., Old, L., and Carswell, E., 1964a, A new antigen found in leukemias and mammary tumours of the mouse, Nature (London) 203:1033–1034.
Stück, B., Old, L., and Boyse, E., 1964b, Occurrence of soluble antigen in the plasma of mice with virus-induced leukemia, Proc. Nat. Acad. Sci. U.S.A. 52:950–958.
Stutman, O., 1975, Immunodepression and malignancy, in Advances in Cancer Research, Vol. 22 (G. Klein, S. Weinhouse, and A. Haddow, eds.), pp. 261–422, Academic Press, New York.
Taylor, G. M., Harris, R., and Freeman, C. B., 1976, Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukemia, Br. J. Cancer 33:137–143.
Ting, C. C., and Herberman, R. B., 1974, Serological analysis of the immune response to Friend virus-induced leukemia, Cancer Res. 34:1676–1683.
Ting, C. C., and Herberman, R. B., 1975, Specific afferent interference by antiserum of in vivo immunity, Nature (London) 253:801–802.
Ting, C. C., and Herberman, R. B., 1976, Humoral host defense mechanisms against tumors, in International Review of Experimental Pathology, Vol. 15 (G. W. Richter and M. A. Epstein, eds.), pp. 93–152. Academic Press, New York.
Ting, C. C., Lavrin, D. H., Shiu, G., and Herberman, R. B., 1972, Expression of fetal antigens in tumor cells, Proc. Nat. Acad. Sci. U.S.A. 69:1664–1668.
Ting, C. C., Kirchner, H., Rodrigues, D., Park, J. Y., and Herberman, R. B., 1976, Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response, J. Immunol. 116:244–252.
Tischendorf, F. W., Ledderose, G., Wilmanns, W., and Tischendorf, M. M., 1973, Cationic leukocyte antigen in urine of patients with chronic myelocytic leukemia, Nature (London) 245:379–380.
Tung, J., Fleissner, E., Vitella, E., and Boyse, E., 1975a, Expression of murine leukemia virus envelope glycoprotein gp 69/71 on mouse thymocytes, J. Exp. Med. 142:518–523.
Tung, J., Vitella, E., and Fleissner, E., 1975b, Biochemical evidence linking the Gix thymocyte surface antigen to the gp 69/71 envelope glycoprotein of murine leukemia virus, J. Exp. Med. 141:198–205.
Ultmann, J. E., Fish, W., Osserman, E., and Gellhorn, A., 1959, The clinical implications of hypogammaglobulinemia in patients with chronic lymphatic leukemia and lymphocytic lymphosarcoma, Ann. Intern. Med. 51:501–516.
Viza, D. C., Bernard-Degani, R., Bernard, C., and Harris, R., 1969, Leukemia antigens, Lancet 2:493–494.
Viza, D., Davies, D. A. L., and Harris, R., 1970, Solubilization and partial purification of human leukaemic specific antigens, Nature (London) 227:1249–1251.
Waldmann, T. A., Broder, S., Krakauer, R., MacDermott, R. P., Durm, M., Goldman, C., and Meade, B., 1976, The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma, Fed. Proc. 35:2067–2072.
Wallen, W. C., and Neubauer, R. H., Rabin, H., and Cicmanec, J., 1973, Nonimmune rosette formation by lymphoma and leukemia cells from herpesvirus saimiri-infected owl monkeys, J. Nat. Cancer Inst. 51:967–975.
Wallen, W. C., Rabin, H., Neubauer, R. H., and Cicmanec, J. L., 1975, Depression in lymphocyte response to general mitogens by owl monkeys infected with herpesvirus saimiri, J. Nat. Cancer Inst. 54:679–685.
West, W., and Herberman, R. B., 1974, A human lymphoid cell line with receptors for both sheep red blood cells and complement, Cell. Immunol. 14:139–145.
Wilson, J. D., and Nossal, G. J. V., 1971, Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukemia, Lancet 2:788–791.
Wybran, J., Chantier, S., and Fudenberg, H. H., 1973, Isolation of normal T cells in chronic lymphatic leukemia, Lancet 1:126–129.
Yata, J., Klein, G., Kobayashi, N., Furukawa, T., and Yanagisawa, M., 1970, Human thymus-lymphoid tissue antigen and its presence in leukaemia and lymphoma, Clin. Exp. Immunol. 7:781–792.
Yohn, D. S., Horoszewicz, J. S., Ellison, R. R., Mittelman, A., and Chai, L. S., 1968, Immunofluorescent studies in human leukemia, Cancer Res. 28:1692–1702.
Yoshida, T. O., and Imai, K., 1970, Autoantibody to human leukemic cell membrane as detected by immune adherence, Rev. Eur. Etud. Clin. Biol. 15:61–65.
Yoshida, T. O., and Andersson, B., 1972, Evidence for a receptor recognizing antigen-complexed immunoglobulin on the surface of activated mouse thymus lymphocytes, Scand. J. Immunol. 1:401–408.
Yoshiki, T., Mellors, R., and Hardy, W., 1973, Common cell-surface antigen associated with murine and feline C type RNA leukemia viruses, Proc. Nat. Acad. Sci. U.S.A. 70:1878–1882.
Yoshiki, T., Mellors, R. C., Hady, W. D., Jr., and Fleissner, E., 1974, Common cell surface antigen associated with mammalian C-type RNA viruses, J. Exp. Med. 139:925–942.
Zarling, J. M., Nowinski, R. C., and Bach, F. H., 1975, Lysis of leukemia cells by spleen cells of normal mice. Proc. Nat. Acad. Sci. U.S.A. 72:2780–2784.
Zatz, M. M., Goldstein, A. L., and White, A., 1973a, Lymphocyte populations of AKR/J mice. I. Effect of aging on migration patterns, response to PHA, and expression of theta antigen, J. Immunol. 111:1514–1518.
Zatz, M. M., White, A., and Goldstein, A. L., 1973b, Lymphocyte populations of AKR/J mice. II. Effect of leukemogenesis on migration patterns, response to PHA, and expression of theta antigen, J. Immunol. 111:1519–1525.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer Science+Business Media New York
About this chapter
Cite this chapter
Herberman, R.B. (1977). Immunological Aspects of Leukemia. In: Gordon, A.S., Silber, R., LoBue, J. (eds) The Year in Hematology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-6688-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4899-6688-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-6690-2
Online ISBN: 978-1-4899-6688-9
eBook Packages: Springer Book Archive